---
figid: PMC4505489__zbc0291519330008
figtitle: NAMPT inhibition leads to alterations of different metabolic pathways in
  cancer cells
organisms:
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
pmcid: PMC4505489
filename: zbc0291519330008.jpg
figlink: /pmc/articles/PMC4505489/figure/F8/
number: F8
caption: NAMPT inhibition leads to alterations of different metabolic pathways in
  cancer cells. NAMPT inhibition affects the glycolytic, pentose phosphate pathway,
  serine biosynthetic pathways, and the TCA cycle. The affected metabolites are highlighted
  in either red (increased) or green (decreased). The blockade of the glyceraldehyde-3-phosphate
  dehydrogenase (G3PDH) step is indicated (×). HK, hexokinase; PGI, phosphoglucose
  isomerase; PFK, phosphofructose kinase; TPI, triose-phosphate isomerase; PGK, phosphoglycerate
  kinase; PGM, phosphoglycerate mutase; PKM2, pyruvate kinase 2; LDH, lactate dehydrogenase;
  G6PDH, glucose-6-phosphate dehydrogenase; G6P, glucose 6-phosphate; 6PGLA, 6-phosphogluconolactonase;
  Gn6P, 6-phosphogluconate; Gn6PDH, 6-phosphogluconate dehydrogenase; NMN, nicotinamide
  mononucleotide adenine; NMNAT, nicotinamide mononucleotide adenine transferase;
  3PG, 3-phosphoglycerate; 3PGDH, 3-phosphoglycerate dehydrogenase; p-ser, phosphoserine;
  PSAT, phosphoserine aminotransferase; PSPH, phosphoserine phosphatase; SHMT, serine
  hydroxymethyltransferase; CS, citrate synthase; IDH, isocitrate dehydrogenase; α-KG,
  α-ketoglutarate; α-KGDH, α-ketoglutarate dehydrogenase; SDH, succinate dehydrogenase;
  FH, fumarate hydratase; MDH, malate dehydrogenase; PDH, pyruvate dehydrogenase;
  F6P, fructose 6-phosphate; FBP, fructose 1,6-bisphosphate; BPG, 1,3-bisphosphoglycerate;
  2PG, 2-phosphoglycerate; PEP, phosphoenolpyruvate; 6PGL, 6-phosphogluconolactone;
  E4P, erythrose 4-phosphate; xylulose5P, xylulose 5-phosphate; ribose5P, ribose 5-phosphate;
  ribulose5P, ribulose 5-phosphate; THF, tetrahydrofolate; MTHF, 5,10-methylenetetrahydrofolate;
  3PHP, 3-phosphohydroxypyruvate; NAM, nicotinamide.
papertitle: Inhibition of Nicotinamide Phosphoribosyltransferase (NAMPT), an Enzyme
  Essential for NAD+ Biosynthesis, Leads to Altered Carbohydrate Metabolism in Cancer
  Cells.
reftext: Bo Tan, et al. J Biol Chem. 2015 Jun 19;290(25):15812-15824.
year: '2015'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.95297
figid_alias: PMC4505489__F8
figtype: Figure
redirect_from: /figures/PMC4505489__F8
ndex: 0b1b54d8-deec-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4505489__zbc0291519330008.html
  '@type': Dataset
  description: NAMPT inhibition leads to alterations of different metabolic pathways
    in cancer cells. NAMPT inhibition affects the glycolytic, pentose phosphate pathway,
    serine biosynthetic pathways, and the TCA cycle. The affected metabolites are
    highlighted in either red (increased) or green (decreased). The blockade of the
    glyceraldehyde-3-phosphate dehydrogenase (G3PDH) step is indicated (×). HK, hexokinase;
    PGI, phosphoglucose isomerase; PFK, phosphofructose kinase; TPI, triose-phosphate
    isomerase; PGK, phosphoglycerate kinase; PGM, phosphoglycerate mutase; PKM2, pyruvate
    kinase 2; LDH, lactate dehydrogenase; G6PDH, glucose-6-phosphate dehydrogenase;
    G6P, glucose 6-phosphate; 6PGLA, 6-phosphogluconolactonase; Gn6P, 6-phosphogluconate;
    Gn6PDH, 6-phosphogluconate dehydrogenase; NMN, nicotinamide mononucleotide adenine;
    NMNAT, nicotinamide mononucleotide adenine transferase; 3PG, 3-phosphoglycerate;
    3PGDH, 3-phosphoglycerate dehydrogenase; p-ser, phosphoserine; PSAT, phosphoserine
    aminotransferase; PSPH, phosphoserine phosphatase; SHMT, serine hydroxymethyltransferase;
    CS, citrate synthase; IDH, isocitrate dehydrogenase; α-KG, α-ketoglutarate; α-KGDH,
    α-ketoglutarate dehydrogenase; SDH, succinate dehydrogenase; FH, fumarate hydratase;
    MDH, malate dehydrogenase; PDH, pyruvate dehydrogenase; F6P, fructose 6-phosphate;
    FBP, fructose 1,6-bisphosphate; BPG, 1,3-bisphosphoglycerate; 2PG, 2-phosphoglycerate;
    PEP, phosphoenolpyruvate; 6PGL, 6-phosphogluconolactone; E4P, erythrose 4-phosphate;
    xylulose5P, xylulose 5-phosphate; ribose5P, ribose 5-phosphate; ribulose5P, ribulose
    5-phosphate; THF, tetrahydrofolate; MTHF, 5,10-methylenetetrahydrofolate; 3PHP,
    3-phosphohydroxypyruvate; NAM, nicotinamide.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ATPsynbeta
  - Atpalpha
  - Hk
  - adp
  - Zw
  - Pgls
  - G6P
  - Pgi
  - Pfk
  - CG15812
  - sip2
  - fbp
  - Aldh-III
  - Ald1
  - Tpi
  - Nmnat
  - Gpdh1
  - Pgk
  - Shmt
  - Pgm1
  - Mthfs
  - Pep
  - bgcn
  - Pdh
  - Pdha
  - Pdf
  - Pdhb
  - mAcon1
  - Mdh1
  - Mdh2
  - Men-b
  - Men
  - Ldh
  - fh
  - LKRSDH
  - SdhB
  - SdhA
  - Sodh-2
  - SdhC
  - Desat2
  - Fadd
  - Fad2
  - Desat1
  - Fancd2
  - DECR1
  - ATP8A2
  - WDTC1
  - H6PD
  - PGLS
  - BGN
  - GPI
  - PGPEP1
  - PFKL
  - PFKM
  - PFKP
  - USF2
  - FBP1
  - FOLR1
  - FOLR2
  - ECB2
  - FUBP1
  - RAB14
  - TPI1
  - NMNAT1
  - NAMPT
  - STAC3
  - PSPH
  - PHGDH
  - PSAT1
  - SHMT1
  - SHMT2
  - VCAN
  - PAEP
  - PREP
  - PTPN22
  - PDP1
  - DLAT
  - DLD
  - PDHA1
  - PDHA2
  - PDHB
  - PDHX
  - RBM14
  - KANK2
  - CACYBP
  - TP53INP1
  - TSACC
  - RBM14-RBM4
  - PKM
  - PKLR
  - IDH2
  - MDH2
  - LDHA
  - LDHB
  - LDHC
  - OGDH
  - FH
  - SARDH
  - SDHB
  - SORD
  - SDS
  - BRCA2
  - FANCD2
  - PSEN1
  - FAD
  - Glucose
  - Glyceraldehyde
  - Glycine
  - Isocitrate
  - Oxaloacetate
  - Pyruvate
  - Ser
  - Succinate
  - Glu
  - Lactate
---
